Physician profile
Gary W Freeberg
NPI 1326086208
$20,809.14
in general payments reported to CMS, 2019-2025
43 companies · $2,644 in 2025
The $2,644 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,134 · 2020: $1,805 · 2021: $2,843 · 2022: $3,309 · 2023: $2,965 · 2024: $3,108 · 2025: $2,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,658 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,658.01 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,322.28 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,801.91 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $2,655.67 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Actelion Pharmaceuticals US, INC. | $1,296.86 | 2019-2025 | Opsumit, Uptravi |
| Genentech USA, INC. | $935.04 | 2019-2024 | Xolair |
| Regeneron Healthcare Solutions, INC. | $890.31 | 2019-2025 | Dupixent |
| Genzyme Corporation | $750.66 | 2020-2025 | |
| Insmed, INC. | $725.43 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $718.09 | 2019-2024 | Yupelri |
| Philips North America LLC | $688.81 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Novartis Pharmaceuticals Corporation | $571.48 | 2019-2024 | |
| Electromed, INC. | $487.14 | 2019-2025 | Smartvest |
| Sunovion Pharmaceuticals INC. | $419.59 | 2019-2020 | |
| Grifols USA, LLC | $397.45 | 2019-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $378.69 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Freeberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.